Sotac Pharmaceuticals Ltd Financials

Sotac Pharmaceuticals Ltd Income Statement

Quarterly

Annual

*All values are in Rs. Cr

Particulars	Sep 2024	Jun 2024	Mar 2024
Revenue	18.09	13.44	16.84
Operating Expense	16.09	10.91	14
Net Profit	0.86	1.25	1.38
Net Profit Margin	4.75	9.30	8.19
Earning Per Share	0.78	1.13	1.25
EBIDTA	2.03	2.55	2.91
Effective Tax Rate	16.50	17.39	19.37

Sotac Pharmaceuticals Ltd Profit & Loss

*All values are in Rs. Cr

Standalone

Consolidated

Particulars	Mar 2023	Mar 2022	Mar 2021
Total Revenue Annual	57.98	73.15	43.44
Operating Expenses Annual	49.77	67.00	40.58
Operating Profit Annual	8.45	6.36	3.21
Interest Annual	0.86	0.55	0.61
Depreciation	1.63	1.13	1.11
Net Profit Annual	4.50	3.30	1.48
Tax Annual	1.47	1.39	TBA

Sotac Pharmaceuticals Ltd Cash Flow

*All values are in Rs. Cr

Standalone

Consolidated

Particulars	Mar 2023	Mar 2022	Mar 2021
Cash Flow at the Beginning	0.03	0.02	0.04
Cash Flow from Operations	8.54	3.58	2.22
Cash Flow from Investing	-10.93	-3.28	-1.07
Cash Flow from Financing	11.97	-0.30	-1.17
Cash Flow at the End	9.60	0.03	0.02

Sotac Pharmaceuticals Ltd Key Ratios

*All values are in Rs. Cr

Standalone

Consolidated

Particulars	Mar 2023	Mar 2022	Mar 2021
PBDIT Margin (%)	14.64	11.25	7.39
PBIT Margin (%)	11.83	9.71	4.83
PBT Margin (%)	-1.33	-7.05	-3.07
Net PROFIT Margin (%)	7.76	4.51	3.41
Return On Networth / Equity (%)	32.04	76.91	34.78
Return On Networth /Employed (%)	29.73	54.73	18.64
Return On Assets (%)	19.48	25.40	13.19
Total Debt / Equity (X)	0.64	1.18	1.64
Asset Turnover Ratio (%)	2.51	5.63	3.87

Sotac Pharmaceuticals Ltd Balance Sheet

*All values are in Rs. Cr

Standalone

Consolidated

Particulars	Mar 2023	Mar 2022	Mar 2021
Fixed Assets Annual	14.09	8.80	6.42
Total Current Assets Annual	36.61	27.50	14.03
Non Current Assets Annual	18.18	8.80	8.46
Total Shareholders Funds Annual	20.99	7.10	4.81
Total Assets Annual	54.78	36.30	22.49